163 related articles for article (PubMed ID: 2783356)
21. Immunogenicity of a new Haemophilus influenzae type b conjugate vaccine (meningococcal protein conjugate) (PedvaxHIB).
Vella PP; Staub JM; Armstrong J; Dolan KT; Rusk CM; Szymanski S; Greer WE; Marburg S; Kniskern PJ; Schofield TL
Pediatrics; 1990 Apr; 85(4 Pt 2):668-75. PubMed ID: 2107517
[TBL] [Abstract][Full Text] [Related]
22. Haemophilus influenzae type b conjugate vaccine (meningococcal protein conjugate) (PedvaxHIB): clinical evaluation.
Ahonkhai VI; Lukacs LJ; Jonas LC; Matthews H; Vella PP; Ellis RW; Staub JM; Dolan KT; Rusk CM; Calandra GB
Pediatrics; 1990 Apr; 85(4 Pt 2):676-81. PubMed ID: 2107518
[TBL] [Abstract][Full Text] [Related]
23. Conjugated Haemophilus influenzae type b vaccine.
Med Lett Drugs Ther; 1988 Apr; 30(764):47-8. PubMed ID: 3258400
[No Abstract] [Full Text] [Related]
24. Persistence of antibody and booster responses to reimmunization with Haemophilus influenzae type b polysaccharide and polysaccharide diphtheria toxoid conjugate vaccines in children initially immunized at 15 to 24 months of age.
Berkowitz CD; Ward JI; Chiu CE; Marcy SM; Gordon L; Hendley JO; Meier K; Marchant CD; McVerry P
Pediatrics; 1990 Mar; 85(3):288-93. PubMed ID: 2304781
[TBL] [Abstract][Full Text] [Related]
25. Haemophilus influenzae type B vaccine in children with sickle cell disease: antibody persistence after vaccination at age one and one-half to six years.
Marcinak JF; Frank AL; Labotka RL; Rao S; Frisone LR; Yogev R; McVerry P
Pediatr Infect Dis J; 1991 Feb; 10(2):157-9. PubMed ID: 2062609
[No Abstract] [Full Text] [Related]
26. Immunity to Haemophilus influenzae type b polysaccharide capsule in children with human immunodeficiency virus infection immunized with a single dose of Haemophilus vaccine.
Peters VB; Sood SK
J Pediatr; 1994 Jul; 125(1):74-7. PubMed ID: 8021791
[TBL] [Abstract][Full Text] [Related]
27. Oligosaccharide-protein conjugate vaccines induce and prime for oligoclonal IgG antibody responses to the Haemophilus influenzae b capsular polysaccharide in human infants.
Insel RA; Anderson PW
J Exp Med; 1986 Feb; 163(2):262-9. PubMed ID: 3484778
[TBL] [Abstract][Full Text] [Related]
28. Immunologic priming to capsular polysaccharide in infants immunized with Haemophilus influenzae type b polysaccharide-Neisseria meningitidis outer membrane protein conjugate vaccine.
Weinberg GA; Einhorn MS; Lenoir AA; Granoff PD; Granoff DM
J Pediatr; 1987 Jul; 111(1):22-7. PubMed ID: 3110388
[TBL] [Abstract][Full Text] [Related]
29. Immunogenicity of Haemophilus influenzae type b conjugate vaccine in children with sickle cell disease.
Rubin LG; Voulalas D; Carmody L
Am J Dis Child; 1992 Mar; 146(3):340-2. PubMed ID: 1543182
[TBL] [Abstract][Full Text] [Related]
30. Keeping children safe: the Haemophilus influenzae type b immunization.
Longyear LA; Clore ER
J Pediatr Health Care; 1987; 1(2):73-6. PubMed ID: 3501010
[No Abstract] [Full Text] [Related]
31. Efficacy of Haemophilus influenzae type b polysaccharide-diphtheria toxoid conjugate vaccine in infancy.
Eskola J; Peltola H; Takala AK; Käyhty H; Hakulinen M; Karanko V; Kela E; Rekola P; Rönnberg PR; Samuelson JS
N Engl J Med; 1987 Sep; 317(12):717-22. PubMed ID: 3306379
[TBL] [Abstract][Full Text] [Related]
32. Impaired antibody response to Haemophilus influenzae type b polysaccharide and low IgG2 and IgG4 concentrations in Apache children.
Siber GR; Santosham M; Reid GR; Thompson C; Almeido-Hill J; Morell A; deLange G; Ketcham JK; Callahan EH
N Engl J Med; 1990 Nov; 323(20):1387-92. PubMed ID: 2233905
[TBL] [Abstract][Full Text] [Related]
33. Characterization of the serum antibody response to the capsular polysaccharide of Haemophilus influenzae type b in children with invasive infections.
Trollfors B; Lagergård T; Claesson BA; Thornberg E; Martinell J; Schneerson R
J Infect Dis; 1992 Dec; 166(6):1335-9. PubMed ID: 1431250
[TBL] [Abstract][Full Text] [Related]
34. Comparative trial in infants of four conjugate Haemophilus influenzae type b vaccines.
Decker MD; Edwards KM; Bradley R; Palmer P
J Pediatr; 1992 Feb; 120(2 Pt 1):184-9. PubMed ID: 1735812
[TBL] [Abstract][Full Text] [Related]
35. Passive immunization for infection with Haemophilus influenzae type b.
Santosham M; Reid R; Letson GW; Wolff MC; Siber G
Pediatrics; 1990 Apr; 85(4 Pt 2):662-6. PubMed ID: 2179857
[TBL] [Abstract][Full Text] [Related]
36. Immunoglobulin deficiency and idiotype expression in children developing Haemophilus influenzae type b disease after vaccination with conjugate vaccine. The Collaborative Study Group.
Holmes SJ; Lucas AH; Osterholm MT; Froeschle JE; Granoff DM
JAMA; 1991 Oct; 266(14):1960-5. PubMed ID: 1895474
[TBL] [Abstract][Full Text] [Related]
37. Haemophilus influenzae disease and immunization in developing countries.
Funkhouser A; Steinhoff MC; Ward J
Rev Infect Dis; 1991; 13 Suppl 6():S542-54. PubMed ID: 1862284
[TBL] [Abstract][Full Text] [Related]
38. [When should vaccination against Haemophilus influenzae type b take place?].
Stickl HA
Med Monatsschr Pharm; 1991 Jan; 14(1):24. PubMed ID: 2017108
[No Abstract] [Full Text] [Related]
39. Haemophilus influenzae type b conjugate vaccine trial in Oxford: implications for the United Kingdom.
Tudor-Williams G; Frankland J; Isaacs D; Mayon-White RT; MacFarlane JA; Rees DG; Moxon ER
Arch Dis Child; 1989 Apr; 64(4):520-4. PubMed ID: 2665657
[TBL] [Abstract][Full Text] [Related]
40. Comparative immune responses to Haemophilus influenzae type b polysaccharide and a polysaccharide-protein conjugate vaccine.
Kim KS; Wong VK; Adler R; Steinberg EA
Pediatrics; 1990 Apr; 85(4 Pt 2):648-50. PubMed ID: 2107516
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
